COVID-19 Pandemic Response: Relief from Additional Co-Payment
To help alleviate the unintended cost impact to ODB program recipients due to measures taken by government in response to COVID-19, the Ministry of Health is proposing to amend O. Reg. 201/96 under the Ontario Drug Benefit Act to ensure recipients are not paying additional co-payments as a result of government's 30-day supply limit recommendation. The cost of the additional co-payments would be shared between the government and dispensers through proposed amendments to dispensing fee rules.
COVID-19 Pandemic Response: Relief from Trillium Drug Program Deductible
To help alleviate the cost impact to Trillium Drug Program (TDP) households as a result of loss of income, the Ministry of Health is proposing to extend the in-year deductible reassessment to include significant income changes that occur in the latter half of the TDP benefit year. This would allow households to use their 2020 income information for the determination of their deductible in the current 2019/20 benefit year (from May 1st until July 31st, 2020).